Clinical development begins with human pharmacology studies, including the initial use of an investigational new drug in humans.

Depending on the characteristics of the drug and the purpose of the development protocol, studies at this stage of development can be conducted in healthy volunteer subjects or specific patient groups with the disease or the disease. It usually involves initial safety and tolerance assessment, pharmacokinetics, pharmacodynamics and early determination of drug activity.